Filter
7139
Filtered Results: 7139
Text search:
access
to
medicines
Featured
Recommendations
620
New Publications
1742
Language
Document type
No document type
3726
Studies & Reports
1453
Guidelines
906
Manuals
396
Strategic & Response Plan
284
Fact sheets
131
Training Material
114
Situation Updates
70
Resource Platforms
24
Infographics
15
Brochures
10
Online Courses
6
App
2
Videos
2
Countries / Regions
Global
310
India
292
Kenya
214
South Africa
174
Ethiopia
150
Uganda
144
Nepal
129
Nigeria
126
Africa
126
Western and Central Europe
124
Sierra Leone
121
Latin America and the Carribbean
120
Tanzania
116
Liberia
110
Malawi
104
Bangladesh
98
Zambia
96
Ukraine
91
Myanmar / Burma
90
Syria
83
Ghana
81
Rwanda
80
Namibia
66
Congo, Democratic Republic of
59
Philippines
54
Zimbabwe
53
South–East Asia Region
50
Eastern Europe
50
Venezuela
48
Mozambique
46
Asia
44
Lesotho
38
East and Southern Africa
37
Senegal
35
Cambodia
35
West and Central Africa
35
Brazil
35
Haiti
33
Yemen
33
Guinea
32
South Sudan
32
Russia
30
Colombia
28
Cameroon
27
Germany
26
Middle East and North Africa
26
Indonesia
26
Burkina Faso
24
Botswana
24
Benin
19
Afghanistan
19
Eswatini/ Swaziland
19
Pakistan
19
Thailand
18
Eastern Europe and Central Asia
18
Vietnam
17
Sudan
16
Peru
15
Lebanon
14
USA
13
Moldova
13
Somalia
13
Tajikistan
12
China
12
Jordan
12
Bolivia
12
Mali
12
Western Pacific Region
11
North America
11
Sri Lanka
11
Paraguay
10
Georgia
10
Central African Republic
10
Ecuador
10
Albania
9
Laos
9
Madagascar
9
North Macedonia
8
Mexico
8
El Salvador
8
Chile
8
Argentina
8
Iraq
8
Turkey
7
Southern Africa
7
Palestine
7
Poland
6
Kazakhstan
5
Iran
5
Kyrgyzstan
5
Jamaica
5
United Kingdom
5
Spain
5
Côte d’Ivoire / Ivory Coast
5
Egypt
5
Timor Leste/ East Timor
4
Canada
4
Burundi
4
Hungary
4
Saudi Arabia
4
Turkmenistan
4
Papua New Guinea
4
Romania
4
Chad
4
Libya
4
Guatemala
4
Switzerland
3
Serbia
3
Gambia
3
Togo
3
Niger
3
Uzbekistan
3
Armenia
3
Portugal
3
Belarus
3
Nicaragua
3
Greece
3
Estonia
2
Malaysia
2
Morocco
2
Qatar
2
Bulgaria
2
Dominican Republic
2
Lithuania
2
Japan
2
France
2
Mauritius
2
Bosnia and Herzegovina
2
Honduras
2
Angola
2
Bhutan
2
Australia
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Austria
1
Mongolia
1
Mauritania
1
Italy
1
Guinea-Bissau
1
Gabon
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Belize
1
Costa Rica
1
Panama
1
Djibouti
1
Slovakia
1
Authors & Publishers
Publication Years
Category
Countries
2646
Clinical Guidelines
547
Public Health
411
Women & Child Health
327
Key Resources
307
Capacity Building
132
Pharmacy & Technologies
78
Annual Report MEDBOX
3
Toolboxes
HIV
644
Mental Health
566
COVID-19
560
TB
417
AMR
278
NTDs
233
Disability
219
Caregiver
216
Planetary Health
208
Conflict
185
Pharmacy
180
NCDs
179
Ebola & Marburg
172
Global Health Education
123
Refugee
114
Malaria
101
Rapid Response
100
Health Financing Toolbox
85
Natural Hazards
67
2.0 Rapid Response
48
Zika
38
Social Ethics
32
Cholera
28
Specific Hazards
26
Polio
17
Typhoon
1
With the growing prevalence of type 2 diabetes, particularly in emerging countries, its management in the context of available resources should be considered. International guidelines, while comprehensive and scientifically valid, may not be appropriate for regions such as Asia, Latin America or Afr...
Access to controlled medicines. 3rd edition
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there...
NLM Launches Emergency Access Initiative, Granting Free Access to Books and Journals for Healthcare Professionals Fighting Ebola Outbreak. The National Library of Medicine (NLM) Emergency Access Initiative (EAI) has been activated to support healthcare professionals working on the Ebola public healt...
Background: Asthma and chronic obstructive pulmonary disease (COPD) cause a considerable burden of morbidity
and mortality in low-income and middle-income countries (LMICs). Access to safe, effective, quality-assured, and
affordable essential medicines is variable. We aimed to review the existing ...
To mark the International Day of the African Child, Medicines for Malaria Venture (MMV) celebrated the inclusion of three of its antimalarial medicines on the WHO Model List of Essential Medicines (EML) and the EML for Children (EMLc). These are two artemisinin-based combination therapies (ACTs) for...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th...
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases. The evaluation combines both quantitative and qualitative anal...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement...
Nearly 90 years after Simon Kuznets first introduced Gross Domestic Product (GDP) for the limited purpose of measuring economic growth (by measuring the monetary value of all local goods and services within a given period of time), calls continue to mount for decision-makers to stop using GDP and it...
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols ...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
